The high molecular homology of liraglutide to the native GLP-1(97% amino acid homology) with great protraction properties may explain the high prevalence of symptomatic cholelithiasis among liraglutide users (81.8%) than other GLP-1RAs [13, 14]. This evidence concerns the gene GLP1R and cholelithiasis.